Li D, Yu Z, Nie C, Wang J. Analysis of
drug factors in 5-aminolevulinic acid photodynamic therapy for oral potentially malignant disorder.
Hua Xi Kou Qiang Yi Xue Za Zhi 2023;
41:701-707. [PMID:
38597036 PMCID:
PMC10722451 DOI:
10.7518/hxkq.2023.2023210]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Received: 07/07/2023] [Revised: 09/28/2023] [Indexed: 04/11/2024]
Abstract
OBJECTIVES
This study aimed to analyze the influence of drug factors on the efficacy of 5-aminolevulinic acid (ALA) photodynamic therapy for oral potentially malignant disorder to improve clinical efficacy and promote clinical rational drug use.
METHODS
Literature on the treatment of oral potentially malignant disorder by using ALA photodynamic therapy was collected and analyzed from PubMed, ISI Web of Knowledge database, CNKI, VIP, and Wanfang database.
RESULTS
A total of 690 cases were collected, with an average complete response rate of 65.94%. The groups treated with 16.8% methyl aminolevulinate cream, local topical, once a week, and pre-activation time of 2-4 hours were better than the other subgroups, with average complete response rates of 100%, 66.91%, 78.28%, and 77.54%, respectively.
CONCLUSIONS
Drug factors have direct influence on the curative effect. The development of novel oral ALA formulations from the perspective of drug improvement is an important strategy to improve efficacy.
Collapse